Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand.
BMC Infect Dis. 2011 Jan 7;11:8. doi: 10.1186/1471-2334-11-8.
Cervical cancer is one of the most common AIDS-related malignancies in Thailand. To prevent cervical cancer, The US Public Health Service and The Infectious Disease Society of America have recommended that all HIV-infected women should obtain 2 Pap smears 6 months apart after the initial HIV diagnosis and, if results of both are normal, should undergo annual cytological screening. However, there has been no evidence in supporting whether this guideline is appropriate in all settings - especially in areas where HIV-infected women are living in resource-constrained condition.
To determine the appropriate interval of Pap smear screenings for HIV-infected Thai women and risk factors for subsequent abnormal cervical cytology, we assessed the prevalence, cumulative incidence and associated factors of cervical cell abnormalities (atypical squamous cell of undetermined significance or higher grades, ASCUS+) among this group of patients.
The prevalence of ASCUS+ was 15.4% at the first visit, and the cumulative incidence of ASCUS+ gradually increased to 37% in the first 3.5 years of follow-up appointments (first 7 times), and tended to plateau in the last 2 years. For multivariate correlation analysis, women with a CD4 count <350 cells/μL had a significant correlation with ASCUS+ (P = 0.043). There were no associations of subsequent ASCUS+ with age, pregnancy, contraceptive method, highly active anti-retroviral treatment, assumed duration of infection, or the CD4 count nadir level.
There are high prevalence and cumulative incidence of ASCUS+ in HIV-infected Thai women. With a high lost-to-follow-up rate, an appropriate interval of Pap smear screening cannot be concluded from the present study. Nevertheless, the HIV-infected Thai women may require more than two normal semi-annual Pap smears before shifting to routinely annual cytologic screening.
宫颈癌是泰国最常见的艾滋病相关恶性肿瘤之一。为了预防宫颈癌,美国公共卫生服务署和美国传染病学会建议所有感染艾滋病毒的妇女在初次诊断 HIV 后应每 6 个月接受 2 次巴氏涂片检查,如果两次结果均正常,应每年进行细胞学筛查。然而,目前尚无证据表明该指南适用于所有情况,尤其是在 HIV 感染妇女生活在资源有限的情况下。
为了确定 HIV 感染泰国妇女进行巴氏涂片筛查的适当间隔以及随后发生异常宫颈细胞学的危险因素,我们评估了这群患者中宫颈细胞异常(非典型鳞状细胞不能明确意义或更高级别,ASCUS+)的患病率、累积发生率和相关因素。
首次就诊时 ASCUS+的患病率为 15.4%,在首次随访预约的前 3.5 年(前 7 次)中,ASCUS+的累积发生率逐渐增加到 37%,并在最后 2 年趋于稳定。对于多变量相关性分析,CD4 计数<350 个/μL 的女性与 ASCUS+有显著相关性(P=0.043)。随后发生 ASCUS+与年龄、妊娠、避孕方法、高效抗逆转录病毒治疗、假设感染持续时间或 CD4 计数最低点水平均无相关性。
HIV 感染的泰国妇女中 ASCUS+的患病率和累积发生率均较高。由于失访率较高,目前的研究无法确定巴氏涂片筛查的适当间隔。然而,HIV 感染的泰国妇女在常规每年细胞学筛查之前可能需要两次以上的正常半年度巴氏涂片检查。